This new formulation provides an additional treatment option for pediatric and adult patients, making the therapy more accessible and convenient in tablet form. Evrysdi, marketed by Genentech ...

This new formulation provides an additional treatment option for pediatric and adult patients, making the therapy more accessible and convenient in tablet form. Evrysdi, marketed by Genentech, a Roche ...

today celebrates the decision by the US Food and Drug Administration (FDA) to grant approval of a risdiplam (Evrysdi) in tablet form, marking a significant advancement in the treatment of spinal ...

The company plans to import a five-month supply of Kodatef while increasing manufacturing output of Arakoda over the long-term. A notice about this information is expected to be posted by FDA on ...

Chi­nese API man­u­fac­tur­ers Wuhu Nuowei Chem­istry and Cheng­du In­no­va­tion Phar­ma­ceu­ti­cal have been placed on US im­port alert over is­sues with their qual­i­ty con­tr ...

VADUZ, Liechtenstein, Feb. 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop ...

Due to concerns about these chemicals’ links to cancer risks, the FDA under the Biden administration ... is a different political party than the prior administration, that creates this world ...

FDA's review has been completed in full and the quality systems/manufacturing module is now considered closed by FDA. Prior to formal PMA approval of RefluxStop™, FDA will perform a pre-approval ...

KODATEF is not approved for use in the U.S. Demand for ARAKODA has been steadily growing in recent months as awareness and ...

This form is required when a tenant leaves personal property within the rental unit, value is believed to be less than $700. The California Notice to Reclaim Abandoned Property (Under $700) notifies a ...